Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients

✍ Scribed by Justin Gillespie; Sinisa Savic; Chi Wong; Aiden Hempshall; Martyn Inman; Paul Emery; Ronald Grigg; Michael F. McDermott

• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 159 KB
• Volume: 64
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.33382